Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Top Sell

Security Buy Sell Buy (1W) Sell (1W) ▼ Price Target price Potential
Revance Therapeutics Inc. 1 2 0 2 €3.08 €3.50 13.636%
Fate Therapeutics Inc. 4 3 1 1 €3.84 €8.27 115.154%
Organovo Holdings Inc. 0 7 0 1 €0.88 - -
Cytomx Therapeutics Inc 1 2 0 1 €1.75 €25.50 1359.645%
Minerva Neurosciences Inc. 1 5 0 0 €2.38 €7.00 194.118%
Coherus Bioscien. 2 2 0 0 €1.93 €3.00 55.199%
Trevena Inc. 1 14 0 0 €0.36 €8.37 2250.112%
Ocuphire Pharma Inc. 6 1 1 0 €1.55 €18.37 1081.853%
Gritstone Oncology Inc 3 2 1 0 €0.71 €6.43 801.121%
Synthetic Biologics Inc. 0 1 0 0 €0.35 - -
Palisade Bio Inc. 3 1 0 0 €0.34 €21.06 6072.333%
Eagle Pharmaceuticals Inc 0 1 0 0 €4.44 - -
Anavex Life Sciences Corp 0 2 0 0 €3.55 - -
Agenus Inc. 3 2 1 0 €0.41 €22.25 5276.897%
Aspira Womens Health Inc. 0 1 0 0 €2.66 - -
Atara Biotherapeutics Inc. 2 3 0 0 €0.52 €3.00 481.621%
Bellicum Pharmaceuticals Inc. 0 13 0 0 €0.064 - -